Assertio Holdings, Inc.
Drug Manufacturers - Specialty & Generic · Healthcare
Board Member
2023-01-01–present
Sravan K. Emany
Board Member
Assertio Holdings, Inc.
Equibles does not estimate personal net worth.
About Sravan K. Emany
Sravan K. Emany is recorded as Board Member at Assertio Holdings, Inc. since May 5, 2026. Assertio Holdings, Inc. reported in an 8-K filed June 16, 2026 that Sravan K. Emany resigned as director, effective June 16, 2026. Assertio Holdings, Inc. reported in an 8-K filed May 7, 2026 that Sravan K. Emany was appointed director, effective May 5, 2026. Assertio Holdings, Inc. reported in an 8-K filed May 13, 2025 that Sravan K. Emany was appointed director, effective May 7, 2025. Equibles holds 5 filed executive changes naming Sravan K. Emany; each is listed under recent activity with its source filing. Assertio Holdings, Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.
“each of Heather L. Mason, Sravan K. Emany, Sigurd C. Kirk, William T. McKee, David M. Stark and Mark L. Reisenauer voluntarily resigned as directors of the Company and from all committees of the Board of Directors (the "Board") of the Company on which such directors served”
“The stockholders of the Company elected each of the six director nominees to serve on the board of directors (the "Board") for a term to expire at the 2027 Annual Meeting of Stockholders and until their successors are elected and qualified, or until their earlier death, retirement, resignation or removal.”
Affiliation history
-
Assertio Holdings, Inc.
Board Member
SEC 8-K
Current2026-05-05–present
-
Assertio Holdings, Inc.
Board Member
Proxy statement
2023-01-01–2026-06-16